Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.59 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | XIAP | P98170 | 1/20 | 0.59 |
| ▸ | ANPEP | P15144 | 3/20 | 0.54 |
| ▸ | RNPEP | Q9H4A4 | 3/20 | 0.54 |
| ▸ | DNPEP | Q9ULA0 | 3/20 | 0.54 |
| ▸ | LTA4H | P09960 | 3/20 | 0.51 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.49 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.49 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.49 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.46 |
| ▸ | CPA1 | P15085 | 2/20 | 0.45 |
| ▸ | CPB1 | P15086 | 1/20 | 0.45 |
| ▸ | CPA3 | P15088 | 1/20 | 0.45 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.45 |
| ▸ | LAP3 | P28838 | 2/20 | 0.43 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dl-Phenylalanine SCHEMBL1253618 | 1.00 | SLC7A5 (0.59) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL7273524 | 0.86 | ALPI (0.44) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL27260374 | 0.86 | ALPI (0.44) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL31087886 | 0.82 | SLC7A5 (0.76) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL208388 | 0.82 | SLC7A5 (0.76) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL10945389 | 0.82 | SLC7A5 (0.76) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL2634732 | 0.82 | SLC7A5 (0.76) | SLC7A5ALPIPKMPTGS1XIAP | |
| D-Phenylalanine SCHEMBL10775923 | 0.82 | SLC7A5 (0.76) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL208389 | 0.82 | SLC7A5 (0.76) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL27551454 | 0.82 | SLC7A5 (0.76) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1409654-B1 | IMMUNOLOGICAL CONTROL OF BETA-AMYLOID LEVELS IN VIVO | BOSTON BIOMEDICAL RES INST (US) | 2008-08-20 | — | — | EP | claimed |
| US-7413884-B2 | Immunological control of β-amyloid levels in vivo | BOSTON BIOMEDICAL RESEARCH INSTITUTE (US) | 2008-08-19 | — | — | US | claimed |
| EP-3070100-B1 | HUMANIZED ANTIBODIES THAT SEQUESTER AMYLOID BETA PEPTIDE | WASHINGTON UNIV ST LOUIS (US) | 2021-07-07 | — | — | EP | disclosed |
| EP-3150633-A1 | HUMANIZED ANTIBODIES THAT SEQUESTER AMYLOID BETA PEPTIDE | WASHINGTON UNIVERSITY ST. LOUIS (US) | 2017-04-05 | — | — | EP | disclosed |
| EP-1481992-B1 | Humanized antibodies that sequester amyloid beta peptide | UNIV ST LOUIS (US) | 2016-11-02 | — | — | EP | disclosed |
| EP-3070100-A1 | HUMANIZED ANTIBODIES THAT SEQUESTER AMYLOID BETA PEPTIDE | WASHINGTON UNIVERSITY ST. LOUIS (US) | 2016-09-21 | — | — | EP | disclosed |
| US-20160039915-A1 | IMMUNOLOGICAL CONTROL OF BETA-AMYLOID LEVELS IN VIVO | BOSTON BIOMEDICAL RESEARCH INSTITUTE (US) | 2016-02-11 | — | — | US | disclosed |
| CN-104341500-A | HUMANIZED ANTIBODIES THAT SEQUESTER A beta PEPTIDE | UNIV WASHINGTON | 2015-02-11 | — | — | CN | disclosed |
| CN-101670105-B | Humanized antibodies chelated with amylord beta peptide | UNIV WASHINGTON | 2014-08-06 | — | — | CN | disclosed |
| US-20140086937-A1 | IMMUNOLOGICAL CONTROL OF BETA-AMYLOID LEVELS IN VIVO | BOSTON BIOMEDICAL RESEARCH INSTITUTE (US) | 2014-03-27 | — | — | US | disclosed |
| US-8591894-B2 | Humanized antibodies that sequester amyloid beta peptide | ELI LILLY AND COMPANY (US) | 2013-11-26 | — | — | US | disclosed |
| US-20030235897-A1 | Immunological control of beta-amyloid levels in vivo | BOSTON BIOMEDICAL RESEARCH INSTITUTE (US) | 2003-12-25 | — | — | US | disclosed |
| CN-1426423-A | Humanized antibodies that sequester amyloid beta peptide | UNIV WASHINGTON (US) | 2003-06-25 | — | — | CN | disclosed |
| US-6582945-B1 | Vectorized antibody for use in the treatment of alzheimer's disease | BOSTON BIOMEDICAL RESEARCH INSTITUTE | 2003-06-24 | — | — | US | disclosed |
| WO-2003016466-A2 | ANTI-Aβ ANTIBODIES | ELI LILLY AND COMPANY (US) | 2003-02-27 | — | — | WO | disclosed |
| EP-1257584-A2 | HUMANIZED ANTIBODIES THAT SEQUESTER AMYLOID BETA PEPTIDE | WASHINGTON UNIVERSITY ST. LOUIS (US) | 2002-11-20 | — | — | EP | disclosed |
| US-20020136718-A1 | Immunological control of beta-amyloid levels in vivo | BOSTON BIOMEDICAL RESEARCH INSTITUTE (US) | 2002-09-26 | — | — | US | disclosed |
| US-20020102261-A1 | Immunological control of beta-amyloid levels in vivo | BOSTON BIOMEDICAL RESEARCH INSTITUTE (US) | 2002-08-01 | — | — | US | disclosed |
| WO-2001062801-A2 | HUMANIZED ANTIBODIES THAT SEQUESTER AMYLOID BETA PEPTIDE | WASHINGTON UNIVERSITY (US) | 2001-08-30 | — | — | WO | disclosed |
| US-6140091-A | GENERATING CATALYTIC ANTIBODIES; IMMUNIZE ANIMAL, SCREEN FOR MONOCLONAL ANTIBODIES, IMMUNIZE ANIMAL WITH ANTIBODY, RECOVER IDIOTYPIC MONOCLONAL ANTIBODIES, IMMUNIZE ANIMAL WITH IDIOTYPIC ANTIBODY AND RECOVER PRODUCT | BOSTON BIOMEDICAL RESEARCH INSTITUTE (US) | 2000-10-31 | — | — | US | disclosed |